Back

Cardiac biomarkers and clinical scores for risk stratification in patients with severe symptomatic aortic stenosis undergoing TAVI. Which ranks first now?

26 August 2017 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Risk stratification and prognosis after TAVI Aortic valve disease ESC Premium Access ESC Congress 2017

About the speaker

Photo
Mrs Anja Stundl

University hospital Bonn, Bonn (Germany)

10 More presentations in this session

Presentation thumbnail
Doctor M. Perrone (Rome, IT)
Presentation thumbnail
Doctor H. Hioki (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Doctor F. Jansen (Cologne, DE)
Abstract Slides
Presentation thumbnail
Mrs A. Stundl (Bonn, DE)
Abstract Slides
Presentation thumbnail
Professor R. Waksman (Washington, DC, US)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Risk stratification and prognosis after TAVI

The Event

Event poster

ESC Congress 2017

26 August 2017 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of baseline wasted myocardial work and serum troponines in severe AS patients referred for TAVR
20 May 2023
thumbnail
Webinar
Aortic stenosis treatment options - which therapy for which patient?
21 December 2021
thumbnail
Webinar
ACVC Biomarker Talk Series - Biomarkers in atrial fibrillation
24 November 2021
thumbnail
Congress Presentation
Urgent transcatheter aortic valve implantation in patients with severe aortic stenosis and acute heart failure
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources